echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Gates Foundation supports anti-HIV and malaria research

    Gates Foundation supports anti-HIV and malaria research

    • Last Update: 2022-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation , including advancing new treatments for HIV and malaria treatments
    .

    fund

    A new commitment from the Bill & Melinda Gates Foundation supports the development of Vir Biotech's "vaccine antibody" technology, an important tool in the fight against infectious diseases worldwide
    .


    Vir Biotech's antibody research program aims to achieve a functional cure for HIV and prevention


    prevention

    The expansion of Vir Biotech's partnership with the Foundation will include advances in innovative platform technology to develop "broadly neutralizing antibodies
    .


    " These antibodies are designed to provide a "vaccine effect" for treating HIV and preventing malaria


    immunity

    Mike McCune, director of the Gates Foundation's HIV Frontiers Program, explained: "Even for those with access to effective antiretroviral treatment, HIV has gone from a recently fatal disease to a chronic one, but it is not a problem for those with access to effective antiretroviral therapy.
    There remains a huge unmet need for new advances in durable antiretroviral-free suppression of HIV
    .


    "

    To support this effort, the Gates Foundation has committed $40 million in equity investments and $10 million in grants
    .


    The program will assess the potential impact of broadly neutralizing antibodies


    To support this effort, the Gates Foundation has committed $40 million in equity investments and $10 million in grants


     

    Original source:

    Original source:

    https:// href="https://" target="_blank" rel="noopener">https:// https:// Leave a comment here

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.